FDA Inspection
Taisho Pharmaceutical (M) SDN BHDTaisho Pharmaceutical (M) SDN BHD – FDA Inspection, Nov 2, 2023
Record Details
This FDA Inspection record concerns Taisho Pharmaceutical (M) SDN BHD, with an inspection on November 2, 2023, issued by the Center for Food Safety and Applied Nutrition, covering food/cosmetics.
View Company Profile
ID · b3db14dd-831c-477d-9b8c-4a5472850d0b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1222097
- FDA center
- Foods & Cosmetics
- Project area
- Foodborne Biological Hazards
- Outcome
- Form 483 issued
FDA Citations
10- 21 CFR 111.155(c)(1)Components - representative samples
- 21 CFR 111.75(a)(1)(i)Component - verify identity, dietary ingredient
- 21 CFR 111.70(b)(1)Specifications - component identity
- 21 CFR 111.75(a)(2)(ii)(A)Component - qualify supplier
- 21 CFR 108.25(c)(1)Registration
- 21 CFR 108.25(c)(1)Registration
- 21 CFR 111.155(c)(1)Components - representative samples
- 21 CFR 111.70(b)(1)Specifications - component identity
- 21 CFR 111.75(a)(1)(i)Component - verify identity, dietary ingredient
- 21 CFR 111.75(a)(2)(ii)(A)Component - qualify supplier
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.